In the new role, Ellison will be responsible for building and manaing the global practice, which has staff in every region of the agency's global network. She will also have direct responsibility for oversight of the US healthcare practice.
She will be based in New York and report to worldwide president and CEO Mark Penn. She will also work closely with US CEO Patrick Ford on managing the US healthcare practice.
Ellison started her career at Burson-Marsteller in the firm's media relations practice, where she was assigned to high-profile projects including The Tylenol Crisis and the First National Breast Cancer Awareness Month. She later returned to Burson-Marsteller as a vice-president in healthcare.
During her career, Ellison has successfully launched more than 30 brands in primary, specialty care and over-the counter markets. Some of her clients have included Bayer, Boehringer Ingelheim, Genentech, GlaxoSmithKline, Schering-Plough, Sepracor and Roche.
Prior to joining Burson-Marsteller, Ellison founded and was president and CEO of HealthStar PR. She has also previously led healthcare divisions at Edelman, Stratis/KPR and Wang Associates.